CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (5,401)	$ (6,187)
Other comprehensive loss:
Available for sale securities - net unrealized loss	(13)	(11)
Cumulative translation adjustment arising during the period	(49)	(12)
Total other comprehensive loss	(62)	(23)
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders	$ (5,463)	$ (6,210)